Total Payments
$3,363
2024 Payments
$978.68
Companies
40
Transactions
158
Medicare Patients
1,087
Medicare Billing
$102,169
Payment Breakdown by Category
Food & Beverage$3,363 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,363 | 158 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merz Pharmaceuticals, LLC | $378.94 | 14 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $366.40 | 17 | $0 (2024) |
| Teva Pharmaceuticals USA, Inc. | $309.98 | 20 | $0 (2024) |
| ABBVIE INC. | $222.54 | 8 | $0 (2024) |
| Allergan, Inc. | $150.88 | 8 | $0 (2022) |
| Celgene Corporation | $143.85 | 8 | $0 (2023) |
| Lilly USA, LLC | $136.07 | 7 | $0 (2024) |
| UCB, Inc. | $127.10 | 5 | $0 (2024) |
| Medtronic USA, Inc. | $102.57 | 4 | $0 (2019) |
| Amneal Pharmaceuticals LLC | $99.03 | 6 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $978.68 | 46 | Merz Pharmaceuticals, LLC ($183.36) |
| 2023 | $707.25 | 32 | Novartis Pharmaceuticals Corporation ($160.62) |
| 2022 | $688.00 | 34 | Celgene Corporation ($87.65) |
| 2021 | $527.26 | 24 | Avanir Pharmaceuticals, Inc. ($66.68) |
| 2020 | $197.16 | 10 | Upsher-Smith Laboratories LLC ($56.80) |
| 2019 | $171.90 | 8 | MicroVention, Inc. ($86.16) |
| 2018 | $93.13 | 4 | Medtronic USA, Inc. ($76.98) |
All Payment Transactions
158 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: Neuropsychiatry | ||||||
| 12/10/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $37.91 | General |
| Category: Musculoskeletal | ||||||
| 11/26/2024 | Merz Pharmaceuticals, LLC | AMPYRA (Drug) | Food and Beverage | In-kind items and services | $31.15 | General |
| Category: Multiple Sclerosis | ||||||
| 10/31/2024 | Merz Pharmaceuticals, LLC | INBRIJA (Drug), AMPYRA | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Parkinson's Disease | ||||||
| 10/24/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $15.18 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
| 10/23/2024 | ARGENX US, INC. | VYVGART HYTRULO (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: Neurology | ||||||
| 10/21/2024 | Cycle Pharmaceuticals Inc | Tascenso ODT (Drug) | Food and Beverage | In-kind items and services | $20.53 | General |
| Category: NEUROLOGY | ||||||
| 10/15/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $23.87 | General |
| Category: Neurology | ||||||
| 10/14/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Immunology | ||||||
| 10/08/2024 | Merz Pharmaceuticals, LLC | AMPYRA (Drug), INBRIJA | Food and Beverage | In-kind items and services | $31.31 | General |
| Category: Multiple Sclerosis | ||||||
| 10/02/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $28.82 | General |
| Category: Neurology | ||||||
| 09/23/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $28.64 | General |
| Category: NEUROSCIENCE | ||||||
| 09/19/2024 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $33.87 | General |
| Category: Musculoskeletal | ||||||
| 09/13/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $21.56 | General |
| Category: Neuroscience | ||||||
| 09/11/2024 | UCB, Inc. | Fintepla (Drug) | Food and Beverage | In-kind items and services | $19.40 | General |
| Category: Neurology | ||||||
| 08/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $26.03 | General |
| Category: Central Nervous System | ||||||
| 08/30/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $2.17 | General |
| Category: Central Nervous System | ||||||
| 08/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.33 | General |
| Category: PAIN | ||||||
| 08/26/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $26.68 | General |
| Category: Neurology | ||||||
| 08/13/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $17.68 | General |
| Category: Immunology | ||||||
| 07/31/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $27.48 | General |
| Category: Neurology | ||||||
| 07/31/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Neuropsychiatry | ||||||
| 07/26/2024 | ABBVIE INC. | DUOPA (Drug) | Food and Beverage | In-kind items and services | $26.22 | General |
| Category: NEUROSCIENCE | ||||||
| 07/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $20.54 | General |
| Category: Immunology | ||||||
| 06/10/2024 | ACADIA Pharmaceuticals Inc | NUPLAZID (Drug) | Food and Beverage | In-kind items and services | $21.23 | General |
| Category: PARKINSONS DISEASE PSYCHOSIS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 217 | 257 | $61,837 | $22,821 |
| 2022 | 7 | 232 | 259 | $57,493 | $20,920 |
| 2021 | 8 | 311 | 360 | $81,891 | $32,455 |
| 2020 | 10 | 327 | 361 | $80,439 | $25,974 |
Total Patients
1,087
Total Services
1,237
Medicare Billing
$102,169
Procedure Codes
32
All Medicare Procedures & Services
32 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 65 | 91 | $17,381 | $6,735 | 38.8% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 40 | 47 | $12,690 | $5,296 | 41.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 25 | 25 | $10,250 | $3,569 | 34.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 32 | 32 | $10,048 | $3,224 | 32.1% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2023 | 12 | 12 | $5,556 | $1,900 | 34.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 20 | 24 | $3,000 | $1,091 | 36.4% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 23 | 26 | $2,912 | $1,006 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 70 | 92 | $17,682 | $6,711 | 38.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 48 | 48 | $15,092 | $4,558 | 30.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 35 | 37 | $10,006 | $4,263 | 42.6% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 19 | 19 | $7,823 | $2,813 | 36.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 36 | 38 | $4,816 | $1,901 | 39.5% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 13 | 14 | $1,568 | $513.12 | 32.7% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 11 | 11 | $506.00 | $160.64 | 31.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 88 | 124 | $23,684 | $10,110 | 42.7% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 72 | 72 | $22,608 | $7,802 | 34.5% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 41 | 49 | $13,230 | $6,180 | 46.7% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Facility | 2021 | 24 | 24 | $9,932 | $3,517 | 35.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 40 | 44 | $5,500 | $2,361 | 42.9% |
| 95911 | Nerve transmission studies, 9-10 studies | Facility | 2021 | 13 | 13 | $4,251 | $1,523 | 35.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Facility | 2021 | 16 | 17 | $1,904 | $682.29 | 35.8% |
| 95885 | Needle measurement and recording of electrical activity of muscles of arm or leg limited study | Facility | 2021 | 17 | 17 | $782.00 | $279.48 | 35.7% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Facility | 2020 | 59 | 59 | $24,280 | $7,829 | 32.2% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 61 | 81 | $16,080 | $5,129 | 31.9% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 68 | 74 | $9,644 | $3,008 | 31.2% |
About Dr. Ziad Alsoufi, MD
Dr. Ziad Alsoufi, MD is a Hospitalist healthcare provider based in Kirkland, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/06/2008. The National Provider Identifier (NPI) number assigned to this provider is 1760652648.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ziad Alsoufi, MD has received a total of $3,363 in payments from pharmaceutical and medical device companies, with $978.68 received in 2024. These payments were reported across 158 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($3,363).
As a Medicare-enrolled provider, Alsoufi has provided services to 1,087 Medicare beneficiaries, totaling 1,237 services with total Medicare billing of $102,169. Data is available for 4 years (2020–2023), covering 32 distinct procedure/service records.
Ad
Practice Information
- Specialty Hospitalist
- Location Kirkland, WA
- Active Since 03/06/2008
- Last Updated 08/18/2016
- Taxonomy Code 208M00000X
- Entity Type Individual
- NPI Number 1760652648
Products in Payments
- Xeomin (Biological) $295.51
- BOTOX (Biological) $213.05
- KESIMPTA (Drug) $169.58
- Austedo XR (Drug) $167.93
- ZEPOSIA (Drug) $166.24
- MAYZENT (Drug) $136.01
- UBRELVY (Drug) $105.51
- Solitaire (Device) $102.57
- RYTARY (Drug) $99.03
- EMGALITY (Drug) $95.49
- NURTEC ODT (Drug) $94.19
- BRIUMVI (Drug) $89.67
- NUPLAZID (Drug) $85.93
- Fintepla (Drug) $80.82
- VYVGART HYTRULO (Drug) $80.58
- Leqembi (Drug) $72.65
- Hizentra (Biological) $68.23
- AUSTEDO (Drug) $66.33
- AMPYRA (Drug) $62.46
- AIMOVIG (Biological) $60.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hospitalist Doctors in Kirkland
Miss. Margaret Kim, M.d, M.D
Hospitalist — Payments: $1,829
Hospitalist $1,829
Dr. Charles Ma, M.d, M.D
Hospitalist — Payments: $828.91
Hospitalist $828.91
Kelly Fujikawa
Hospitalist — Payments: $198.71
Hospitalist $198.71
Mary Lacy, M.d, M.D
Hospitalist — Payments: $11.92
Hospitalist $11.92
Dr. Nancy Marshall, Md, MD
Hospitalist
Hospitalist
Dr. Tristan Osborn, Md, MD
Hospitalist
Hospitalist